Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26+0.00 (0.00%)
Close on Nov 19, 2026Market cap $248.90MP/E –Yield –
Amarin shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Amarin's shares outstanding was 428M at Sep 30, 2026. For fiscal 2025 it was 415M, up 1.0% from the year before. Over ten years it grew 8.7% a year on average. The highest annual figure on record is 415M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 415M | +1.0% |
| FY2024 | Dec 31, 2024 | 411M | +0.8% |
| FY2023 | Dec 31, 2023 | 408M | +1.6% |
| FY2022 | Dec 31, 2022 | 401M | -0.3% |
| FY2021 | Dec 31, 2021 | 402M | +5.4% |
| FY2020 | Dec 31, 2020 | 382M | +11.5% |
| FY2019 | Dec 31, 2019 | 343M | +15.2% |
| FY2018 | Dec 31, 2018 | 297M | +9.8% |
| FY2017 | Dec 31, 2017 | 271M | +27.7% |
| FY2016 | Dec 31, 2016 | 212M | +17.3% |
| FY2015 | Dec 31, 2015 | 181M | +3.9% |
| FY2014 | Dec 31, 2014 | 174M | +4.0% |
| FY2013 | Dec 31, 2013 | 167M | +16.0% |
| FY2012 | Dec 31, 2012 | 144M | +110472.2% |
| FY2011 | Dec 31, 2011 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 428M | +3.0% |
| Q2 FY2026 | Jun 30, 2026 | 416M | +0.5% |
| Q1 FY2026 | Mar 31, 2026 | 419M | +1.4% |
| Q4 FY2025 | Dec 31, 2025 | 416M | +1.1% |
| Q3 FY2025 | Sep 30, 2025 | 416M | +1.1% |
| Q2 FY2025 | Jun 30, 2025 | 414M | +0.7% |
| Q1 FY2025 | Mar 31, 2025 | 413M | +0.8% |
| Q4 FY2024 | Dec 31, 2024 | 411M | +0.8% |
| Q3 FY2024 | Sep 30, 2024 | 411M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | 411M | +0.9% |
| Q1 FY2024 | Mar 31, 2024 | 410M | +1.0% |
| Q4 FY2023 | Dec 31, 2023 | 408M | +0.8% |
| Q3 FY2023 | Sep 30, 2023 | 408M | +0.9% |
| Q2 FY2023 | Jun 30, 2023 | 408M | +2.4% |
| Q1 FY2023 | Mar 31, 2023 | 406M | +2.1% |
| Q4 FY2022 | Dec 31, 2022 | 405M | -4.3% |
| Q3 FY2022 | Sep 30, 2022 | 405M | +2.0% |
| Q2 FY2022 | Jun 30, 2022 | 398M | -0.9% |
| Q1 FY2022 | Mar 31, 2022 | 398M | +0.8% |
| Q4 FY2021 | Dec 31, 2021 | 423M | +8.2% |
| Q3 FY2021 | Sep 30, 2021 | 397M | +1.8% |
| Q2 FY2021 | Jun 30, 2021 | 402M | +0.5% |
| Q1 FY2021 | Mar 31, 2021 | 395M | +9.3% |
| Q4 FY2020 | Dec 31, 2020 | 391M | +8.7% |
| Q3 FY2020 | Sep 30, 2020 | 390M | +11.0% |
| Q2 FY2020 | Jun 30, 2020 | 400M | +20.8% |
| Q1 FY2020 | Mar 31, 2020 | 361M | +9.9% |
| Q4 FY2019 | Dec 31, 2019 | 359M | +14.3% |
| Q3 FY2019 | Sep 30, 2019 | 351M | +18.7% |
| Q2 FY2019 | Jun 30, 2019 | 331M | +12.7% |
| Q1 FY2019 | Mar 31, 2019 | 329M | +15.3% |
| Q4 FY2018 | Dec 31, 2018 | 314M | +16.0% |
| Q3 FY2018 | Sep 30, 2018 | 296M | +9.2% |
| Q2 FY2018 | Jun 30, 2018 | 294M | +8.5% |
| Q1 FY2018 | Mar 31, 2018 | 285M | +5.6% |
| Q4 FY2017 | Dec 31, 2017 | 271M | +0.5% |
| Q3 FY2017 | Sep 30, 2017 | 271M | – |
| Q2 FY2017 | Jun 30, 2017 | 271M | – |
| Q1 FY2017 | Mar 31, 2017 | 270M | – |
| Q4 FY2016 | Dec 31, 2016 | 270M | – |
See a number that looks wrong?